Takase Y - Search Results

1

Thrombin in the synovial fluid of patients with rheumatoid arthritis mediates proliferation of synovial fibroblast-like cells by induction of platelet derived growth factor.

Ohba T, Takase Y, Ohhara M, Kasukawa R. Ohba T, et al. Among authors: takase y. J Rheumatol. 1996 Sep;23(9):1505-11. J Rheumatol. 1996. PMID: 8877916

2

Idiopathic thrombocytopenic purpura complicated by intracranial hemorrhage in a 78-year-old male.

Kobayashi H, Sagawa K, Watanabe N, Morito T, Kazuta Y, Takase Y, Kasukawa R. Kobayashi H, et al. Among authors: takase y. Fukushima J Med Sci. 1995 Jun;41(1):79-86. Fukushima J Med Sci. 1995. PMID: 8606045

3

Primary Sjögren's syndrome complicated by sarcoidosis.

Miyata M, Takase Y, Kobayashi H, Kokubun M, Yoshimura A, Katsuura Y, Nishimaki T, Kasukawa R. Miyata M, et al. Among authors: takase y. Intern Med. 1998 Feb;37(2):174-8. doi: 10.2169/internalmedicine.37.174. Intern Med. 1998. PMID: 9550600 Free article. Review.

4

Cyclic GMP phosphodiesterase inhibitors. 2. Requirement of 6-substitution of quinazoline derivatives for potent and selective inhibitory activity.

Takase Y, Saeki T, Watanabe N, Adachi H, Souda S, Saito I. Takase Y, et al. J Med Chem. 1994 Jun 24;37(13):2106-11. doi: 10.1021/jm00039a024. J Med Chem. 1994. PMID: 8027992

5

4-Benzylamino-1-chloro-6-substituted phthalazines: synthesis and inhibitory activity toward phosphodiesterase 5.

Watanabe N, Kabasawa Y, Takase Y, Matsukura M, Miyazaki K, Ishihara H, Kodama K, Adachi H. Watanabe N, et al. Among authors: takase y. J Med Chem. 1998 Aug 27;41(18):3367-72. doi: 10.1021/jm970815r. J Med Chem. 1998. PMID: 9719589

6

4-(3-Chloro-4-methoxybenzyl)aminophthalazines: synthesis and inhibitory activity toward phosphodiesterase 5.

Watanabe N, Adachi H, Takase Y, Ozaki H, Matsukura M, Miyazaki K, Ishibashi K, Ishihara H, Kodama K, Nishino M, Kakiki M, Kabasawa Y. Watanabe N, et al. Among authors: takase y. J Med Chem. 2000 Jun 29;43(13):2523-9. doi: 10.1021/jm9905054. J Med Chem. 2000. PMID: 10891111

7

A selective type V phosphodiesterase inhibitor, E4021, dilates porcine large coronary artery.

Saeki T, Adachi H, Takase Y, Yoshitake S, Souda S, Saito I. Saeki T, et al. Among authors: takase y. J Pharmacol Exp Ther. 1995 Feb;272(2):825-31. J Pharmacol Exp Ther. 1995. PMID: 7853200

8

Cyclic GMP phosphodiesterase inhibitors. 1. The discovery of a novel potent inhibitor, 4-((3,4-(methylenedioxy)benzyl)amino)-6,7,8-trimethoxyquinazoline.

Takase Y, Saeki T, Fujimoto M, Saito I. Takase Y, et al. J Med Chem. 1993 Nov 26;36(24):3765-70. doi: 10.1021/jm00076a003. J Med Chem. 1993. PMID: 8254606

9

Structure-activity relationship of N-[2-(dimethylamino)-6-[3-(5-methyl-4-phenyl-1H-imidazol-1-yl)propoxy] phenyl]-N'-pentylurea and analogues. Novel potent inhibitors of acyl-CoA:cholesterol O-acyltransferase with antiatherosclerotic activity.

Kimura T, Takase Y, Hayashi K, Tanaka H, Ohtsuka I, Saeki T, Kogushi M, Yamada T, Fujimori T, Saitou I, et al. Kimura T, et al. Among authors: takase y. J Med Chem. 1993 May 28;36(11):1630-40. doi: 10.1021/jm00063a013. J Med Chem. 1993. PMID: 8496930

10

Determination of a novel and potent cyclic GMP phosphodiesterase inhibitor, 4-([3,4-(methylenedioxy)-benzyl]amino)-6,7,8-trimethoxyquinazoline, in dog plasma by high-performance liquid chromatography.

Tokumura T, Takase Y, Horie T. Tokumura T, et al. Among authors: takase y. J Chromatogr B Biomed Appl. 1994 Aug 5;658(1):202-6. doi: 10.1016/0378-4347(94)00186-3. J Chromatogr B Biomed Appl. 1994. PMID: 7952126

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

439 results

Search Page